Business Context and Reporting Period
Company: AptarGroup, Inc.
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 1996
Business Overview: AptarGroup is a multinational supplier of dispensing packaging systems, including pumps, dispensing closures, and aerosol valves. The company serves the fragrance/cosmetics, personal care, pharmaceutical, household, and food industries. It operates primarily in North America and Europe, with over 1,000 customers and approximately 3,900 employees. No single customer accounted for more than 10% of 1996 net sales.
Key Financial Metrics
Revenue and Profit: The filing text does not provide specific values for total net sales, net income, or profit margins for the year ended December 31, 1996. These figures are incorporated by reference from the 1996 Annual Report to Stockholders (pages 18-34).
Cash Flow and Liquidity: Specific cash flow and liquidity metrics are not provided in the text. The Consolidated Statements of Cash Flows are incorporated by reference.
Debt: The text notes that the company historically borrows locally to hedge currency fluctuations but does not disclose total debt levels or interest rates.
Research and Development: R&D expenditures were $20.1 million in 1996, compared to $17.5 million in 1995 and $15.3 million in 1994.
Market Capitalization: As of March 20, 1997, the aggregate market value of Common Stock held by non-affiliates was approximately $587,478,000. There were 17,957,039 shares of Common Stock outstanding.
Allowance for Doubtful Accounts: The balance at the end of 1996 was $3,623,000.
Material Changes and Operational Highlights
- Product Mix: In 1996, pump sales accounted for approximately 63% of net sales, dispensing closures for 18%, and aerosol valves for 17%.
- Geographic Expansion: The company established a manufacturing facility in China, which began producing aerosol valves in early 1997. Production of dispensing closures and pumps was planned for later in 1997.
- Acquisitions: Recent acquisitions included Liquid Molding Silicone Molded Systems, Inc. (LMS) and General Plastics, S.A. in 1995, adding significant molding technologies.
- International Sales: Sales in Europe represented approximately 58% of net sales in 1996, down slightly from 60% in 1995.
- Manufacturing: Approximately 96% of finished products were manufactured or assembled at facilities owned or leased by AptarGroup.
Outlook, Risks, and Management Commentary
Outlook and Strategy: Management expects continued growth in the use of pumps for pharmaceuticals and cosmetics (e.g., anti-aging lotions). The company aims to expand market share in Europe, South America, and Asia for dispensing closures and to convert non-dispensing closures to dispensing systems in the food and household markets.
Risks and Contingencies:
- Foreign Currency: A significant portion of operations is in Europe. A strengthening U.S. dollar would negatively impact financial results, while a weakening dollar has a positive translation effect.
- Regulatory Environment: Government regulations regarding Volatile Organic Compounds (VOCs) may restrain aerosol valve growth. Regulations on medical cost containment could affect pharmaceutical sales.
- Competition: Markets are highly competitive with price pressure. Competitors range from regional to international entities.
- Supply Chain: The company is dependent on certain suppliers for unique technical components; delays could impact short-term supply and increase costs.
- Legal Proceedings: Pending claims relate to product liability and patent infringement. Management does not expect a material adverse effect, though product liability claims may increase with pharmaceutical applications.
Investor Verification Checklist
- Verify total net sales, net income, and earnings per share in the Consolidated Statements of Income (incorporated by reference).
- Review the Consolidated Balance Sheets for total debt, working capital, and liquidity positions.
- Confirm the impact of foreign currency fluctuations on the 1996 results as detailed in the Management's Discussion and Analysis.
- Assess the progress of the new China manufacturing facility and its contribution to 1997 revenue.
- Monitor regulatory changes regarding VOCs and pharmaceutical pricing that could impact demand for aerosol valves and pumps.